Literature DB >> 2982949

Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.

P A Fitzgerald, M Mendelsohn, C Lopez.   

Abstract

Studies were undertaken to determine whether natural killer (NK) cells could inhibit the replication of herpes simplex virus type 1 (HSV-1) in culture. In the absence of effector cells, HSV-1 was found to replicate in fibroblasts with up to a 100-fold increase in virus titer from 4 to 16 hr after incubation at 37 degrees C. Human peripheral blood mononuclear cells were found to limit virus replication in a dose-dependent manner, with the greatest inhibition being observed at the highest concentration evaluated: i.e., an effector:target ratio of 800:1. The antiviral effect was not observed when nonactivated or virus-activated mononuclear cells were added to the virus preparations at the end (instead of the beginning) of the assay period, indicating that the observed effect was not due to a nonspecific toxicity of soluble factors released from freeze-thawed effectors. Neither was inhibition of HSV-1 replication due to the generation of interferon (IFN) during the NK assay, because the addition of anti-IFN did not abrogate the antiviral effect. Thus, the inhibition of viral replication was most likely due to a cytotoxic effector rather than to release of soluble factors. The effector cells responsible for limiting HSV-1 replication were shown to be NK cells by a number of criteria. Mononuclear cells from both HSV-1 seropositive and seronegative donors limited virus replication; their activity could be boosted by pretreatment of effector cells with IFN; the effector cells which limited virus replication were found in Percoll gradient fractions enriched for large granular lymphocytes; and the effector cells shared the cell surface phenotype of NK cells--they were enriched in populations depleted of T cells by panning with Leu-4 and were depleted of activity by treatment with the anti-NK antibody Leu-11b plus complement. We conclude that human NK cells are capable of recognizing and lysing HSV-1-infected target cells before infectious virus progeny are generated. These results suggest that NK cells, acting early in the course of an infection, might serve to limit HSV-1 replication and therefore reduce the virus load in the host before the development of the adaptive immune response and clearance of the infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982949

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Reduced degranulation of NK cells in patients with frequently recurring herpes.

Authors:  Vladimir V Murugin; Irina N Zuikova; Nina E Murugina; Andrey E Shulzhenko; Boris V Pinegin; Mikhail V Pashenkov
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

2.  Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.

Authors:  G Rappocciolo; J F Toso; D J Torpey; P Gupta; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Non-productive infection of human newborn blood mononuclear cells with herpes simplex virus: effect on T cell activation, IL-2 production and proliferation.

Authors:  A Hayward; M Laszlo; M Turman; A Vafai; D Tedder
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  The in situ cellular immune response in acute herpes simplex encephalitis.

Authors:  R A Sobel; A B Collins; R B Colvin; A K Bhan
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

6.  Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction.

Authors:  A Ahmad; E Sharif-Askari; L Fawaz; J Menezes
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.

Authors:  J Tarkkanen; E Saksela
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.

Authors:  P J Leibson; M Hunter-Laszlo; G S Douvas; A R Hayward
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

9.  Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells.

Authors:  P J Leibson; M Hunter-Laszlo; A R Hayward
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.

Authors:  D S Kaufman; R A Schoon; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.